( LSE:GSK,NYSE:GSK )

News from glaxosmithkline plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jun 02, 2016, 11:00 ET Regulatory update on US filing plans for closed triple combination therapy FF/UMEC/VI in patients with COPD

GlaxoSmithKline plc (LSE: GSK) and Innoviva, Inc. (Nasdaq: INVA) today announced that, following discussions with the US Food and Drug...


Feb 22, 2016, 11:06 ET GSK's Global HIV Business ViiV Healthcare Completes Transactions to Acquire Bristol-Myers Squibb's R&D HIV Assets

GlaxoSmithKline plc (LSE: GSK) today announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and...


Dec 02, 2015, 09:00 ET GSK Announces Nucala® (mepolizumab), Now Available In The Us For Sub-Group Of Patients With Severe Asthma

 GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that Nucala® (mepolizumab), the first and only biologic add-on therapy for people 12...


Dec 02, 2015, 09:00 ET GSK Announces Nucala® (mepolizumab), Now Available In The Us For Sub-Group Of Patients With Severe Asthma

 GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that Nucala® (mepolizumab), the first and only biologic add-on therapy for people 12...


Nov 09, 2015, 08:00 ET GSK, COPD Foundation and AARC Team Up for #COPDChat, November 9th, 12 pm ET

GlaxoSmithKline plc (LSE: GSK) today announced a tweet chat with the COPD Foundation and American Association for Respiratory Care (AARC) to raise...


Apr 30, 2015, 16:36 ET FDA approves BREO® ELLIPTA® for the treatment of adults with asthma in the US

GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved...


Aug 26, 2014, 15:52 ET GSK receives FDA approval of an additional Promacta® (eltrombopag) indication for use in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST)

GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug...


Aug 21, 2014, 09:30 ET The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International

 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the...


Apr 30, 2014, 18:27 ET GSK receives approval for Incruse™ Ellipta® (umeclidinium) in the US for the treatment of COPD

 GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Incruse™ Ellipta®...


Apr 28, 2014, 08:54 ET Anoro™ Ellipta® now available in the US for treatment of COPD

GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that Anoro™ Ellipta® (umeclidinium and...


Apr 15, 2014, 14:26 ET GSK receives US approval for once-weekly type 2 diabetes treatment, Tanzeum™ (albiglutide)

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Tanzeum™ (albiglutide) for...


Dec 11, 2013, 17:55 ET New England Journal of Medicine releases study showing GSK's FluLaval Quadrivalent vaccine effective in preventing seasonal flu in children

 GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that a peer-reviewed study issued online by the New England Journal of Medicine has...